Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 2009

View Archived Issues

Novel piperidine derivatives claimed by Astellas Pharma

Novel anaplastic lymphoma kinase inhibitors claimed by IRM

Nitric oxide releasing derivatives of paracetamol patented

Bardoxolone methyl improves renal function in patients with chronic kidney disease

Novel antibacterial agents claimed by AstraZeneca

Novel protein kinase inhibitors described by IRM for the treatment of asthma

Atrial natriuretic peptide prevents contrast-induced nephropathy in patients with renal failure

Leflunomide acts as an immunosuppressant in kidney and/or pancreas transplant patients

Pre- and in-hospital initiation of tirofiban show similar benefits in myocardial infarction patients

Statin dose effect on HDL-cholesterol not uniform across agents

Dosing of anakinra in experimental myocardial infarction investigated

BioAlliance to complete NDA for Loramyc with new data

Donor lymphocyte infusion therapy increases post stem-cell transplantation survival rates

Results from a phase III study of Nuvigil in jet lag disorder announced by Cephalon

FDA Advisory Committee reviews Seroquel XR supplemental NDA

Merck & Co. and Cardiome sign license agreement for vernakalant for atrial fibrillation

Myriad receives IND approval for new cancer drug, MPC-3100

Nippon Shinyaku and Lilly enter agreement for new tadalafil indications

Othera reports interim phase II OT-551 results for dry AMD

Cell Therapeutics initiates rolling NDA for pixantrone

Prometheus and Rosetta Genomics enter license and collaboration agreement

Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis

Aegis and Phylogica collaborate to deliver intranasal Phylomer peptide drugs

Celldex Therapeutics enhances immunotherapy platform

PAION and Ergomed report phase II data for CNS-5161 in neuropathic cancer pain

Ipsen provides update of FDA's review of its botulinum toxin type A product

Glenmark's molecule for neuropathic pain, GRC-10693, completes phase I trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...